Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

NCT00211952 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

542

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: celecoxib

Sponsor

Medical University of Gdansk

Collaborators

[object Object]
[object Object]
[object Object]